A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

Vos, R; Vanaudenaerde, B M; Verleden, S E; De Vleeschauwer, S I; Willems-Widyastuti, A; Van Raemdonck, D E; Schoonis, A; Nawrot, T S; Dupont, L J; Verleden, G M

Vos, R; Vanaudenaerde, B M; Verleden, S E; De Vleeschauwer, S I; Willems-Widyastuti, A; Van Raemdonck, D E; Schoonis, A; Nawrot, T S; Dupont, L J; Verleden, G M.

Affiliation

Vos R; Laboratory of Pneumology, Lung Transplantation Unit, University Hospital Gasthuisberg, Leuven, Belgium.

Eur Respir J ; 37(1): 164-72, 2011 Jan.

Article in En | MEDLINE | ID: mdl-20562124

Subject(s)

Azithromycin/therapeutic use; Graft Rejection/prevention & control; Immunosuppressive Agents/therapeutic use; Lung Transplantation/methods; Adult; Bronchiolitis Obliterans/prevention & control; Disease-Free Survival; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Placebos; Proportional Hazards Models; Transplantation, Homologous; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lung Transplantation / Azithromycin / Graft Rejection / Immunosuppressive Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur Respir J Year: 2011 Type: Article Affiliation country: Belgium

Fulltext

XML

PubMed Links

Search on Google